Publications by authors named "Alexander Huether"

Claim this Profile
H
Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.
Viola Baradari, Michael Höpfner, Alexander Huether, Detlef Schuppan, Hans Scherübl

World J Gastroenterol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma.
Alexander Huether, Michael Höpfner, Viola Baradari, Detlef Schuppan, Hans Scherübl

Biochem Pharmacol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells.
Viola Baradari, Alexander Huether, Michael Höpfner, Detlef Schuppan, Hans Scherübl

Endocr Relat Cancer· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine kinase of insulin-like growth factor receptor as target for novel treatment and prevention strategies of colorectal cancer.
Michael Hopfner, Andreas P Sutter, Alexander Huether, Viola Baradari, Hans Scherubl

World J Gastroenterol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.
Alexander Huether, Michael Hopfner, Andreas P Sutter, Viola Baradari, Detlef Schuppan

World J Gastroenterol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells.
Michael Höpfner, Alexander Huether, Andreas P Sutter, Viola Baradari, Detlef Schuppan

Biochem Pharmacol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the epidermal growth factor receptor by erlotinib (Tarceva) for the treatment of esophageal cancer.
Andreas P Sutter, Michael Höpfner, Alexander Huether, Kerstin Maaser, Hans Scherübl

Int J Cancer· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours.
Michael Höpfner, Viola Baradari, Alexander Huether, Christof Schöfl, Hans Scherübl

Endocr Relat Cancer· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors. Synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor.
Andreas P Sutter, Kerstin Maaser, Michael Höpfner, Alexander Huether, Detlef Schuppan

J Hepatol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer.
Alexander Huether, Michael Höpfner, Viola Baradari, Detlef Schuppan, Hans Scherübl

Biochem Pharmacol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics.
Alexander Huether, Michael Höpfner, Andreas P Sutter, Detlef Schuppan, Hans Scherübl

J Hepatol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.
Michael Höpfner, Andreas P Sutter, Alexander Huether, Detlef Schuppan, Martin Zeitz

J Hepatol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel approach in the treatment of neuroendocrine gastrointestinal tumors: additive antiproliferative effects of interferon-gamma and meta-iodobenzylguanidine.
Michael Höpfner, Andreas P Sutter, Alexander Huether, Gudrun Ahnert-Hilger, Hans Scherübl

BMC Cancer· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis